Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula empírica (notación de Hill):
C3H4O2
Número CAS:
Peso molecular:
72.06
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352103
EC Number:
200-340-1
MDL number:
Assay:
≥90%
Quality level:
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarletype
Grade II
Quality Level
assay
≥90%
refractive index
n20/D 1.412 (lit.)
bp
162 °C (lit.)
mp
−33 °C (lit.)
density
1.146 g/mL at 25 °C (lit.)
storage temp.
−20°C
SMILES string
O=C1CCO1
InChI
1S/C3H4O2/c4-3-1-2-5-3/h1-2H2
InChI key
VEZXCJBBBCKRPI-UHFFFAOYSA-N
General description
β-Propiolactone is an alkylating agent which is mainly used in veterinary vaccines. It will not interfere with the antigenicity of vaccine.
Application
β-Propiolactone has been used for Influenza virus deactivation.
Disclaimer
Insoluble polymers may form during storage.
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 2 Inhalation - Carc. 1B - Eye Irrit. 2 - Skin Irrit. 2
Clase de almacenamiento
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
wgk
WGK 3
flash_point_f
158.0 °F - closed cup
flash_point_c
70 °C - closed cup
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Vesla I Kullaya et al.
Viral immunology, 30(8), 576-581 (2017-08-08)
Detection of respiratory syncytial virus (RSV) in blood, including mononuclear leukocytes and organs other than the lung, suggests that RSV disseminates outside the respiratory tract. In this study, the role of platelets in host defense against RSV was explored using
Veterinary Immunology-E book, 262-262 (2013)
Tiago Abreu-Mota et al.
Nature communications, 9(1), 4223-4223 (2018-10-13)
Lassa fever (LF), caused by Lassa virus (LASV), is a viral hemorrhagic fever for which no approved vaccine or potent antiviral treatment is available. LF is a WHO priority disease and, together with rabies, a major health burden in West

